ICOS is required for the generation of both central and effector CD4+ memory T-cell populations following acute bacterial infection

Research output: Contribution to journalArticlepeer-review

Standard

ICOS is required for the generation of both central and effector CD4+ memory T-cell populations following acute bacterial infection. / Marriott, Clare L.; Carlesso, Gianluca; Herbst, Ronald; Withers, David R.

In: European Journal of Immunology, Vol. 45, No. 6, 05.06.2015, p. 1706–1715.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Bibtex

@article{dee9ac019a6a457f80d82d8cce35c765,
title = "ICOS is required for the generation of both central and effector CD4+ memory T-cell populations following acute bacterial infection",
abstract = "Interactions between ICOS and ICOS ligand (ICOSL) are essential for the development of T follicular helper (Tfh) cells and thus the formation and maintenance of GC reactions. Given the conflicting reports on the requirement of other CD4+ T-cell populations for ICOS signals, we have employed a range of in vivo approaches to dissect requirements for ICOS signals in mice during an endogenous CD4+ T-cell response and contrasted this with CD28 signals. Genetic absence of ICOSL only modestly reduced the total number of antigen-specific CD4+ T cells at the peak of the primary response, but resulted in a severely diminished number of both T central memory and T effector memory cells. Treatment with blocking anti-ICOS mAb during the primary response recapitulated these effects and caused a more substantial reduction than blocking CD28 signals with CTLA4Ig. During the memory phase of the response further signals through ICOS or CD28 were not required for survival. However, upon secondary challenge only Tfh cell expansion remained heavily ICOS-dependent, while CD28 signals were required for optimal expansion of all subsets. These data demonstrate the importance of ICOS signals specifically for memory CD4+ T-cell formation, while highlighting the potential of therapeutically targeting this pathway.",
keywords = "ICOS, CD28, CD4+ Memory, T-cell responses, Tfh",
author = "Marriott, {Clare L.} and Gianluca Carlesso and Ronald Herbst and Withers, {David R.}",
note = "{\textcopyright} 2015 The Authors. European Journal of Immunology published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.",
year = "2015",
month = jun,
day = "5",
doi = "10.1002/eji.201445421",
language = "English",
volume = "45",
pages = "1706–1715",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "6",

}

RIS

TY - JOUR

T1 - ICOS is required for the generation of both central and effector CD4+ memory T-cell populations following acute bacterial infection

AU - Marriott, Clare L.

AU - Carlesso, Gianluca

AU - Herbst, Ronald

AU - Withers, David R.

N1 - © 2015 The Authors. European Journal of Immunology published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PY - 2015/6/5

Y1 - 2015/6/5

N2 - Interactions between ICOS and ICOS ligand (ICOSL) are essential for the development of T follicular helper (Tfh) cells and thus the formation and maintenance of GC reactions. Given the conflicting reports on the requirement of other CD4+ T-cell populations for ICOS signals, we have employed a range of in vivo approaches to dissect requirements for ICOS signals in mice during an endogenous CD4+ T-cell response and contrasted this with CD28 signals. Genetic absence of ICOSL only modestly reduced the total number of antigen-specific CD4+ T cells at the peak of the primary response, but resulted in a severely diminished number of both T central memory and T effector memory cells. Treatment with blocking anti-ICOS mAb during the primary response recapitulated these effects and caused a more substantial reduction than blocking CD28 signals with CTLA4Ig. During the memory phase of the response further signals through ICOS or CD28 were not required for survival. However, upon secondary challenge only Tfh cell expansion remained heavily ICOS-dependent, while CD28 signals were required for optimal expansion of all subsets. These data demonstrate the importance of ICOS signals specifically for memory CD4+ T-cell formation, while highlighting the potential of therapeutically targeting this pathway.

AB - Interactions between ICOS and ICOS ligand (ICOSL) are essential for the development of T follicular helper (Tfh) cells and thus the formation and maintenance of GC reactions. Given the conflicting reports on the requirement of other CD4+ T-cell populations for ICOS signals, we have employed a range of in vivo approaches to dissect requirements for ICOS signals in mice during an endogenous CD4+ T-cell response and contrasted this with CD28 signals. Genetic absence of ICOSL only modestly reduced the total number of antigen-specific CD4+ T cells at the peak of the primary response, but resulted in a severely diminished number of both T central memory and T effector memory cells. Treatment with blocking anti-ICOS mAb during the primary response recapitulated these effects and caused a more substantial reduction than blocking CD28 signals with CTLA4Ig. During the memory phase of the response further signals through ICOS or CD28 were not required for survival. However, upon secondary challenge only Tfh cell expansion remained heavily ICOS-dependent, while CD28 signals were required for optimal expansion of all subsets. These data demonstrate the importance of ICOS signals specifically for memory CD4+ T-cell formation, while highlighting the potential of therapeutically targeting this pathway.

KW - ICOS

KW - CD28

KW - CD4+ Memory

KW - T-cell responses

KW - Tfh

U2 - 10.1002/eji.201445421

DO - 10.1002/eji.201445421

M3 - Article

C2 - 25754933

VL - 45

SP - 1706

EP - 1715

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 6

ER -